Results 191 to 200 of about 38,270 (217)

Functional Precision in Pancreatic Cancer: Redefining Biomarkers with Patient-Derived Organoids. [PDF]

Int J Mol Sci
Chew CA, Wun CM, Lee YF, Chee CE, Ho KY, Bonney GK.   +5 more
europepmc   +1 more source

Taurine suppresses gastric intestinal metaplasia in patient-derived organoids and <i>Atp4a</i> ^-/- mice. [PDF]

World J Gastrointest Oncol
Liu K, Zhang X, Li FZ, Zheng PY, Mi Y.
europepmc   +1 more source

Patient-derived organoids in hepatobiliary pancreatic cancer research: Their uses and limitations. [PDF]

World J Gastroenterol
Jacobs S, Butterworth W, Griffiths EA.
europepmc   +1 more source

Patient-Derived Organoids as a Platform to Decipher and Overcome Radioresistance: From the Tumor Microenvironment to Radiosensitizer Discovery. [PDF]

Curr Oncol
Yin D, Hong X, Wang X, Ding W, Wang C, Qian J, Zhou Y, Sun C, Wu Z.   +8 more
europepmc   +1 more source

From benchside avatars to bedside breakthroughs: Patient-derived organoids in the new era of cancer immunotherapy. [PDF]

Transl Oncol
Mi Z, Guan H, Zhang G, Li D, Yu Y, Qu J.
europepmc   +1 more source

Microfluidic-based patient-derived organoids recapitulate thyroid cancer heterogeneity and reveal NF-κB-driven maturation for precision therapy. [PDF]

J Transl Med
Gao H, Lin J, Chen X, Su Y, Huang Y, Zhang Y, Zhang J, Xu N, Dai X.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Patient‐ and xenograft‐derived organoids recapitulate pediatric brain tumor features and patient treatments

EMBO Molecular Medicine, 2023
Claudio Ballabio, Chiara Lago, Alessia Soldano   +2 more
exaly  

Patient-Derived Cancer Organoids as Predictors of Treatment Response

Frontiers in Oncology, 2021
Dirk De Ruysscher, Maikel Verduin, Ann Hoeben   +2 more
exaly